Procedure guideline for detection of inflammation with F-18 FDG PET/CT in cardiac sarcoidosis
dc.authorscopusid | 55222520800 | |
dc.authorscopusid | 7006337323 | |
dc.authorscopusid | 55929946400 | |
dc.authorscopusid | 7005518886 | |
dc.authorscopusid | 57197259576 | |
dc.authorscopusid | 16640643100 | |
dc.contributor.author | Sen F. | |
dc.contributor.author | Demir H. | |
dc.contributor.author | Altun G.D. | |
dc.contributor.author | Özdemir E. | |
dc.contributor.author | Özdemir S. | |
dc.contributor.author | Tosun F.C. | |
dc.date.accessioned | 2024-06-12T10:26:22Z | |
dc.date.available | 2024-06-12T10:26:22Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Histologic confirmation of cardiac sarcoidosis (CS) is challenging. When taken into account of either the invasive nature or potential false negativity of the endomyocardial biopsy, imaging methods represent as a major alternative to establish a clinical diagnosis. Among the imaging methods, the use of fluorine-18-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) which detects active inflammation in CS is becoming widespread. Recently, F-18 FDG PET has been identified as one of the new diagnostic criteria in CS, by the Heart Rhythm Society. For diagnosis, a combination of both myocardial perfusion and inflammation findings should be interpreted visually and/or semiquantitatively. Yet, the precision of diagnostic accuracy has been limited by lack of an adequate reference standard. This procedure guideline presents current literature defining the role of F-18 FDG PET in the diagnosis and management of CS along with technical details and recommendations about imaging protocol and interpretation. © 2020 Nuclear Medicine Seminars. All Rights Reserved. | en_US |
dc.identifier.doi | 10.4274/NTS.GALENOS.2020.0015 | |
dc.identifier.endpage | 219 | en_US |
dc.identifier.issn | 2149-6447 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.scopus | 2-s2.0-85183311138 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 211 | en_US |
dc.identifier.uri | https://doi.org/10.4274/NTS.GALENOS.2020.0015 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/16803 | |
dc.identifier.volume | 6 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | tr | en_US |
dc.publisher | Galenos Publishing House | en_US |
dc.relation.ispartof | Nuclear Medicine Seminars | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cardiac Sarcoidosis; F-18 Fdg Pet/Ct; Inflammation | en_US |
dc.subject | Fluorodeoxyglucose F 18; Article; Cardiac Sarcoidosis; Diagnostic Accuracy; Diagnostic Test Accuracy Study; Heart Muscle Perfusion; Human; Inflammation; Positron Emission Tomography-Computed Tomography; Practice Guideline; Standard | en_US |
dc.title | Procedure guideline for detection of inflammation with F-18 FDG PET/CT in cardiac sarcoidosis | en_US |
dc.title.alternative | Kardiyak Sarkoidozda F-18 FDG PET/BT ile Enflamasyon Görüntüleme Kilavuzu | en_US |
dc.type | Article | en_US |